Brain-Derived Neurotrophic Factor Is Related with Sarcopenia in Patients with Disease-Related Malnutrition
Annals of Nutrition and Metabolism · 2025
DOI: 10.1159/000546418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Nutrition and Metabolism, 2025. Verfasst von Daniel de Luis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Investigation of Endocrinology and Clinical Nutrition, Medicine School, Department Endocrinology and Nutrition, Hospital Clinico Universita…. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Sarcopenia, Malnutrition. Die Arbeit nennt 25 Literaturangaben.
Themen: Mangelernährung
Abstract (Originalsprache)
Introduction
Sarcopenia is a condition characterized by muscle mass loss. Some investigations have demonstrated the role of brain-derived neurotrophic factor (BDNF) as a protector against the presence of sarcopenia in patients with chronic kidney disease. We aimed to explore the role of circulating BDNF in the development of sarcopenia among individuals with disease-related malnutrition (DRM). Materials and Methods: A total of 160 patients diagnosed with DRM according to the Global Leadership Initiative on Malnutrition (GLIM) criteria were enrolled. Anthropometric data, muscle mass assessed via ultrasound at the rectus femoris quadriceps (RFQ) level, bioelectrical impedance analysis (skeletal muscle mass [SMM], appendicular skeletal muscle mass [aSMM], and appendicular skeletal muscle mass index [aSMMI]), handgrip strength, biochemical parameters, dietary intake, and circulating levels of BDNF were measured.
Results
A total of 55 patients (34.4%) were classified as sarcopenic, while 105 patients (65.6%) were classified as non-sarcopenic. Phase angle (−0.6 ± 0.2°; p = 0.01), reactance (−5.8 ± 2.1 Ohms; p = 0.03), SMM (−3.3 ± 0.2 kg; p = 0.04), aSMM (−2.1 ± 0.3 kg; p = 0.03), aSMMI (−0.8 ± 0.2 kg; p = 0.03), dominant muscle area (−0.7 ± 0.2 cm2; p = 0.04), and dominant Y-axis thickness (−0.4 ± 0.1 cm; p = 0.03) were worse in patients with sarcopenia. Muscle strength was higher in non-sarcopenic patients (8.5 ± 1.2 kg; p = 0.01). Circulating BDNF levels were significantly higher in non-sarcopenic patients compared to sarcopenic patients (94.7 ± 3.9 ng/mL; p = 0.01). Logistic regression analysis indicated a reduced risk of sarcopenia (OR = 0.16, 95% CI = 0.11–0.43; p = 0.03) in patients with higher BDNF levels, after adjusting for body mass index, gender, energy intake, and age.
Conclusion
Our study identified an association between low serum BDNF levels and sarcopenia in patients with DRM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Investigation of Endocrinology and Clinical Nutrition, Medicine School, Department Endocrinology and Nutrition, Hospital Clinico Universitario, University of Valladolid, Valladolid, Spain.
Zitieren
APA
de Luis, D., Primo, D., Izaola, O., & López Gómez, J. J. (2025). Brain-Derived Neurotrophic Factor Is Related with Sarcopenia in Patients with Disease-Related Malnutrition. Annals of Nutrition and Metabolism. https://doi.org/10.1159/000546418
Vancouver
de Luis D, Primo D, Izaola O, López Gómez JJ. Brain-Derived Neurotrophic Factor Is Related with Sarcopenia in Patients with Disease-Related Malnutrition. Annals of Nutrition and Metabolism. 2025. doi:10.1159/000546418
BibTeX
@article{deLuis2025,
author = {de Luis, Daniel and Primo, David and Izaola, Olatz and López Gómez, Juan José},
title = {Brain-Derived Neurotrophic Factor Is Related with Sarcopenia in Patients with Disease-Related Malnutrition},
journal = {Annals of Nutrition and Metabolism},
year = {2025},
doi = {10.1159/000546418}
}
EUVIMED